Cart
sales@molnova.com
Succinylcholine Chloride Dihydrate
CAS No. 6101-15-1
Succinylcholine Chloride Dihydrate( —— )
Catalog No. M18889 CAS No. 6101-15-1
Succinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 10MG | 31 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 110 | In Stock |
|
| 200MG | 198 | In Stock |
|
| 500MG | 334 | In Stock |
|
| 1G | 496 | In Stock |
|
Biological Information
-
Product NameSuccinylcholine Chloride Dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuccinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.
-
DescriptionSuccinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
Recptornicotinic AChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number6101-15-1
-
Formula Weight397.34
-
Molecular FormulaC14H30N2O4·2Cl·2H2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO.O.[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dihydrolipoic acid
Dihydrolipoic acid, a dithiol-containing carboxylic acid, acts as a general antioxidant that is highly reactive against a variety of reactive oxygen species, including peroxynitirite, hydroxyl radicals, hydrogen peroxide, and hypochlorite, at concentrations ranging from 0.01-0.5 mM.
-
LY310762
LY310762 is a 5-HT1D receptor antagonist with Ki of 249 nM.
-
5,6-Benzoflavone
5,6-Benzoflavone (β-Naphthoflavone) is an exogenous ligand for the aryl hydrocarbon receptor, which disrupts zinc homeostasis in human hepatocellular carcinoma HepG2 cells.
